EUVIMEDEUVIMED entdecken
Open Access

Assessing the Impact of Exposure Misclassification in Case–Control Studies of Self‐Reported Medication Use

Nedghie Adrien iD, Richard F MacLehose, Martha M Werler iD, Mahsa M Yazdy, Matthew P Fox, Samantha E Parker iD, National Birth Defects Prevention Study

Paediatric and Perinatal Epidemiology · 2026

DOI: 10.1111/ppe.13161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Paediatric and Perinatal Epidemiology, 2026. Verfasst von Nedghie Adrien und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Pregnancy Complications, Prenatal Exposure Delayed Effects, Maternal Exposure. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA, EPA, NCBDD CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Empirically evaluating the potential impact of recall bias on observed associations of prenatal medication exposure is crucial.

Objective

We sought to assess the effects of exposure misclassification on previous studies of the use of nonsteroidal anti‐inflammatory drugs (NSAIDs) in early pregnancy and increased risk of amniotic band syndrome (ABS).

Methods

Using data from the National Birth Defects Prevention Study (NBDPS) on births from 1997 to 2011, we included 189 mothers of infants with ABS and 11,829 mothers of infants without congenital anomalies. We identified external studies of medication use during pregnancy to obtain validity parameters for a probabilistic bias analysis to adjust for exposure misclassification. Due to uncertainty about the transportability of these parameters, we conducted multidimensional bias analyses to explore combinations of values on the results.

Results

When we assumed higher specificity in cases or higher sensitivity in controls, misclassification‐adjusted estimates suggested confounding‐adjusted estimates were attenuated. However, in a few instances, when we assumed greater sensitivity in the cases than the controls (and Sp ≥ 0.9), the misclassification‐adjusted estimates suggested upward bias in the confounding‐adjusted estimates.

Conclusions

Results from our bias analysis highlighted that the magnitude of bias depended on the mechanism and the extent of misclassification. However, the parameters available from the validation studies were not directly applicable to our study. In the absence of reliable validation studies, considering mechanisms of bias and simulation studies to outline combinations of plausible scenarios to better inform conclusions on the effects of these medications on pregnancy outcomes remains important.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalPregnancy ComplicationsPrenatal Exposure Delayed EffectsMaternal ExposureHumansFemalePregnancyCase-Control StudiesSelf ReportBiasAdultInfant, NewbornUnited States

Stichwörter der Autor:innen

anti‐inflammatory agentscongenital abnormalitiesepidemiological biasesmisclassificationnonsteroidal

Substanzen

Anti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Division for Surveillance, Research, and Promotion of Perinatal Health, Massachusetts Department of Public Health, Boston, Massachusetts, USA.
  • Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.

ORCID-Profile: Nedghie Adrien, Martha M Werler, Samantha E Parker

Förderung

  • HSRD VA
  • EPA
  • NCBDD CDC HHS
  • NIH HHS
  • NICHD NIH HHS
  • CDC HHS
  • Centers for Disease Control and Prevention
  • National Institutes of Health

Zitieren

APA

Adrien, N., MacLehose, R. F., Werler, M. M., Yazdy, M. M., Fox, M. P., Parker, S. E., & National Birth Defects Prevention Study (2026). Assessing the Impact of Exposure Misclassification in Case–Control Studies of Self‐Reported Medication Use. Paediatric and Perinatal Epidemiology. https://doi.org/10.1111/ppe.13161

Vancouver

Adrien N, MacLehose RF, Werler MM, Yazdy MM, Fox MP, Parker SE, et al. Assessing the Impact of Exposure Misclassification in Case–Control Studies of Self‐Reported Medication Use. Paediatric and Perinatal Epidemiology. 2026. doi:10.1111/ppe.13161

BibTeX
@article{Adrien2026,
  author = {Adrien, Nedghie and MacLehose, Richard F and Werler, Martha M and Yazdy, Mahsa M and Fox, Matthew P and Parker, Samantha E and National Birth Defects Prevention Study, National Birth Defects Prevention Study},
  title = {Assessing the Impact of Exposure Misclassification in Case–Control Studies of Self‐Reported Medication Use},
  journal = {Paediatric and Perinatal Epidemiology},
  year = {2026},
  doi = {10.1111/ppe.13161}
}
Kostenlos starten →